Literature DB >> 33496225

Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020.

Grace M Vahey, Kristen E Marshall, Emily McDonald, Stacey W Martin, Jacqueline E Tate, Claire M Midgley, Marie E Killerby, Breanna Kawasaki, Rachel K Herlihy, Nisha B Alden, J Erin Staples.   

Abstract

To improve recognition of coronavirus disease (COVID-19) and inform clinical and public health guidance, we randomly selected 600 COVID-19 case-patients in Colorado. A telephone questionnaire captured symptoms experienced, when symptoms occurred, and how long each lasted. Among 128 hospitalized patients, commonly reported symptoms included fever (84%), fatigue (83%), cough (73%), and dyspnea (72%). Among 236 nonhospitalized patients, commonly reported symptoms included fatigue (90%), fever (83%), cough (83%), and myalgia (74%). The most commonly reported initial symptoms were cough (21%-25%) and fever (20%-25%). In multivariable analysis, vomiting, dyspnea, altered mental status, dehydration, and wheezing were significantly associated with hospitalization, whereas rhinorrhea, headache, sore throat, and anosmia or ageusia were significantly associated with nonhospitalization. General symptoms and upper respiratory symptoms occurred earlier in disease, and anosmia, ageusia, lower respiratory symptoms, and gastrointestinal symptoms occurred later. Symptoms should be considered alongside other epidemiologic factors in clinical and public health decisions regarding potential COVID-19 cases.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; SARS-CoV-2; coronavirus disease; hospitalization; respiratory infections; severe acute respiratory syndrome coronavirus 2; symptom duration; symptom progression; symptoms; viruses; zoonoses

Mesh:

Year:  2021        PMID: 33496225      PMCID: PMC7853576          DOI: 10.3201/eid2702.203729

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  39 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  Accuracy and bias in retrospective symptom reporting.

Authors:  Omer Van den Bergh; Marta Walentynowicz
Journal:  Curr Opin Psychiatry       Date:  2016-09       Impact factor: 4.741

Review 3.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

4.  Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.

Authors:  Marlene M Speth; Thirza Singer-Cornelius; Michael Oberle; Isabelle Gengler; Steffi J Brockmeier; Ahmad R Sedaghat
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-19       Impact factor: 3.497

5.  Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects.

Authors:  Alberto Paderno; Davide Mattavelli; Vittorio Rampinelli; Alberto Grammatica; Elena Raffetti; Michele Tomasoni; Tommaso Gualtieri; Stefano Taboni; Silvia Zorzi; Francesca Del Bon; Davide Lombardi; Alberto Deganello; Luca Oscar Redaelli De Zinis; Alberto Schreiber
Journal:  Otolaryngol Head Neck Surg       Date:  2020-06-30       Impact factor: 3.497

6.  Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.

Authors:  Mark W Tenforde; Sara S Kim; Christopher J Lindsell; Erica Billig Rose; Nathan I Shapiro; D Clark Files; Kevin W Gibbs; Heidi L Erickson; Jay S Steingrub; Howard A Smithline; Michelle N Gong; Michael S Aboodi; Matthew C Exline; Daniel J Henning; Jennifer G Wilson; Akram Khan; Nida Qadir; Samuel M Brown; Ithan D Peltan; Todd W Rice; David N Hager; Adit A Ginde; William B Stubblefield; Manish M Patel; Wesley H Self; Leora R Feldstein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-07-31       Impact factor: 17.586

7.  COVID-19: what is next for public health?

Authors:  David L Heymann; Nahoko Shindo
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321

8.  Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.

Authors:  Andrea Giacomelli; Laura Pezzati; Federico Conti; Dario Bernacchia; Matteo Siano; Letizia Oreni; Stefano Rusconi; Cristina Gervasoni; Anna Lisa Ridolfo; Giuliano Rizzardini; Spinello Antinori; Massimo Galli
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

9.  Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States.

Authors:  Yael R Nobel; Meaghan Phipps; Jason Zucker; Benjamin Lebwohl; Timothy C Wang; Magdalena E Sobieszczyk; Daniel E Freedberg
Journal:  Gastroenterology       Date:  2020-04-12       Impact factor: 22.682

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  9 in total

1.  Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection.

Authors:  Eik Schäfer; Christian Scheer; Karen Saljé; Anja Fritz; Thomas Kohlmann; Nils-Olaf Hübner; Matthias Napp; Lizon Fiedler-Lacombe; Dana Stahl; Bernhard Rauch; Matthias Nauck; Uwe Völker; Stephan Felix; Guglielmo Lucchese; Agnes Flöel; Stefan Engeli; Wolfgang Hoffmann; Klaus Hahnenkamp; Mladen V Tzvetkov
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

2.  Use of Favipiravir for the Treatment of Coronavirus Disease 2019 in the Setting of Hospitel.

Authors:  Bhitta Surapat; Warissa Kobpetchyok; Sasisopin Kiertiburanakul; Vanlapa Arnuntasupakul
Journal:  Int J Clin Pract       Date:  2022-03-29       Impact factor: 3.149

3.  Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients.

Authors:  A Faycal; A L Ndoadoumgue; B Sellem; C Blanc; Y Dudoit; L Schneider; R Tubiana; M-A Valantin; S Seang; R Palich; A Bleibtreu; G Monsel; N Godefroy; O Itani; O Paccoud; V Pourcher; E Caumes; N Ktorza; A Chermak; B Abdi; L Assoumou; C Katlama
Journal:  Infect Dis Now       Date:  2021-11-17

4.  Case-control study to identify risk factors for SARS-CoV-2 infection among university students in the northeastern USA.

Authors:  Kevin J Cummings; Marin Clarkberg; Jefferson Busche; Alexander J Travis; Genevive R Meredith; Isaac Weisfuse; Casey L Cazer; Gary A Koretzky; Lorin D Warnick
Journal:  Transbound Emerg Dis       Date:  2022-06-29       Impact factor: 4.521

5.  Secondary bacterial infections are a leading factor triggering New Onset Atrial Fibrillation in intubated ICU Covid-19 ARDS patients.

Authors:  George E Zakynthinos; Vasiliki Tsolaki; Nikitas Karavidas; Vassileios Vazgiourakis; George Dimeas; Konstantinos Mantzarlis; George Vavougios; Demosthenes Makris
Journal:  J Infect Public Health       Date:  2022-06-16       Impact factor: 7.537

6.  Missing science: A scoping study of COVID-19 epidemiological data in the United States.

Authors:  Rajiv Bhatia; Isabella Sledge; Stefan Baral
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

7.  Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis.

Authors:  Sujata Purja; Hocheol Shin; Ji-Yun Lee; EunYoung Kim
Journal:  Arch Pharm Res       Date:  2021-07-24       Impact factor: 6.010

Review 8.  COVID-19: comprehensive review on mutations and current vaccines.

Authors:  Ananda Vardhan Hebbani; Swetha Pulakuntla; Padmavathi Pannuru; Sreelatha Aramgam; Kameswara Rao Badri; Vaddi Damodara Reddy
Journal:  Arch Microbiol       Date:  2021-12-06       Impact factor: 2.552

9.  xsGastrointestinal symptoms are associated with a lower risk of hospitalization and mortality and Outcomes in COVID-19.

Authors:  Alireza Delavari; Samaneh Asgari; Yousef Alimohamadi; Abbass Vosoogh-Moghaddam; Anahita Sadeghi; Shokouh Shahrousvand; Armin Zakeri; Rahmatollah Moradzadeh; Samaneh Akbarpour
Journal:  BMC Gastroenterol       Date:  2022-03-10       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.